BlackRock’s Minerva Surgical, Inc. Common Stock UTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,695
Closed -$7.44K 5646
2023
Q1
$7.44K Buy
1,695
+57
+3% +$351 ﹤0.01% 5345
2022
Q4
$7.32K Buy
1,638
+38
+2% +$252 ﹤0.01% 5493
2022
Q3
$25K Sell
1,600
-387
-19% -$14.7K ﹤0.01% 5480
2022
Q2
$93K Buy
1,987
+1,166
+142% +$67.5K ﹤0.01% 5261
2022
Q1
$74K Sell
821
-39
-5% -$3.96K ﹤0.01% 5350
2021
Q4
$88K Buy
+860
New +$122K ﹤0.01% 5311

Other funds holding UTRS

BlackRock's UTRS Position: Q2 2023 in Review

BlackRock sold out of Minerva Surgical, Inc. Common Stock (UTRS) in Q2 2023, closing a stake of 1,695 shares — an estimated $7.44K sold.

BlackRock first reported a position in UTRS in Q4 2021 and held it in 6 quarters. The position peaked at $93K in Q2 2022. 17 funds tracked by Wall St. Rank hold UTRS as of Q2 2023.

  • BlackRock reported no remaining Minerva Surgical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • BlackRock sold 1,695 Minerva Surgical, Inc. Common Stock shares in Q2 2023, an estimated $7.44K.
  • BlackRock first reported a position in Minerva Surgical, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • BlackRock's Minerva Surgical, Inc. Common Stock position peaked at $93K in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Minerva Surgical, Inc. Common Stock as of Q2 2023.

Based on BlackRock's 13F filing for Q2 2023, filed 11 Aug 2023.